Company / Cash per Share
Cartesian Therapeutics, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$4.86
FY2025
5-year range
$0.50 / $39.39
FY2021-FY2025
Trend
-87.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 8 years, ranging from $0.50 in FY2023 to $39.39 in FY2024.
Based on SEC 10-K filings.
4.86 in FY2025 with a 5-year CAGR of +36.1%.
Improved from $0.50 to $4.86 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +74.0%
- 5-Year CAGR
- +36.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 87.7% year-over-year.
- Peak cash per share was recorded in FY2024.
- Lowest cash per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.86 | -87.7% |
| FY2024 | $39.39 | +7738.0% |
| FY2023 | $0.50 | -45.5% |
| FY2022 | $0.92 | -28.1% |
| FY2021 | $1.28 | +23.2% |
| FY2020 | $1.04 | -37.4% |
| FY2019 | $1.66 | -78.2% |
| FY2016 | $7.63 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026